FDG uptake and epidermal growth factor receptor (EGFR) mutations in patients (pts) with lung adenocarcinoma

被引：0
|
作者：
Rensi, Marco [1 ]
Giacomuzzi, Francesco [1 ]
De Maglio, Giovanna [1 ]
Bonutti, Faustino [1 ]
Stanic, Davide [1 ]
Fasola, Gianpiero [1 ]
Pizzolitto, Stefano [1 ]
Geatti, Onelio [1 ]
机构：
[1] Univ Hosp, Udine, Italy
来源：
JOURNAL OF NUCLEAR MEDICINE | 2015年 / 56卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
236
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations
    Kim, Min Hwan
    Kim, Hye Ryun
    Cho, Byoung Chul
    Bae, Mi Kyung
    Kim, Eun Young
    Lee, Chang Young
    Lee, Jae Seok
    Kang, Dae Ryong
    Kim, Joo Hang
    LUNG CANCER, 2014, 84 (02) : 196 - 202
  • [22] Good Response to Gefitinib in Lung Adenocarcinoma of Complex Epidermal Growth Factor Receptor (EGFR) Mutations with the Classical Mutation Pattern
    Wu, Shang-Gin
    Chang, Yih-Leong
    Hsu, Ya-Chieh
    Wu, Jenn-Yu
    Yang, Chih-Hsin
    Yu, Chong-Jen
    Tsai, Meng-Feng
    Shih, Jin-Yuan
    Yang, Pan-Chyr
    ONCOLOGIST, 2008, 13 (12): : 1276 - 1284
  • [23] Prognostic implications of mutations in the epidermal growth factor receptor (EGFR) and KRAS among never-smokers with adenocarcinoma of the lung
    Paik, P. K.
    Johnson, M. L.
    D'Angelo, S. P.
    Sima, C.
    Janjigian, Y. Y.
    Riely, G. J.
    Kris, M. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] Clinical outcomes of lung adenocarcinoma patients harboring uncommon epidermal growth factor receptor (EGFR) mutations treated with EGFR-tyrosine kinase inhibitors (TKIs)
    Si, Jinfei
    Gu, Xiaodong
    Wang, Wenxian
    Ying, Shenpeng
    Song, Zhengbo
    ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (05) : 1624 - 1634
  • [25] Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplilications, and KRAS mutations on survival of pancreatic adenocarcinoma
    Lee, Jeeyun
    Jang, Kee-Taek
    Ki, Chang-Seok
    Lim, Taekyu
    Park, Young Suk
    Lim, Ho Yeong
    Choi, Dong-Wook
    Kaing, Won Ki
    Park, Keunchil
    Park, Joon Oh
    CANCER, 2007, 109 (08) : 1561 - 1569
  • [26] Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data
    Jorge, S. E. D. C.
    Kobayashi, S. S.
    Costa, D. B.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2014, 47 (11) : 929 - 939
  • [27] Prevalence of the epidermal growth factor receptor mutations in lung adenocarcinoma patients from the Middle East region
    Tfayli, Arafat Hussein
    Fakhri, Ghina Bassam
    Al Assaad, Majd Sassine
    ANNALS OF THORACIC MEDICINE, 2019, 14 (03) : 173 - 178
  • [28] Sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in males, smokers, and non-adenocarcinoma lung cancer in patients with EGFR mutations
    Zeng, Zhu
    Chen, Hua-jun
    Yan, Hong-hong
    Yang, Jin-ji
    Zhang, Xu-chao
    Wu, Yi-long
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2013, 28 (03): : 249 - 258
  • [29] Prognostic value of epidermal growth factor receptor mutations and histologic subtypes with lung adenocarcinoma
    Motono, Nozomu
    Funasaki, Aika
    Sekimura, Atsushi
    Usuda, Katsuo
    Uramoto, Hidetaka
    MEDICAL ONCOLOGY, 2018, 35 (03)
  • [30] Two Unusual Mutations in the Epidermal Growth Factor Receptor Gene in a Patient With Lung Adenocarcinoma
    Laguado, Martin Zapata
    Zuluaga, Andrea
    Medina, Rafael Parra
    Bruges, Ricardo
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
12345